386 related articles for article (PubMed ID: 22032724)
21. [Detecting Large Germline Rearrangements of BRCA1 by Next Generation Tumor Sequencing].
Minucci A; Mazzuccato G; Marchetti C; Pietragalla A; Scambia G; Fagotti A; Urbani A
Mol Biol (Mosk); 2020; 54(4):688-698. PubMed ID: 32840490
[TBL] [Abstract][Full Text] [Related]
22. Fusion transcript discovery in formalin-fixed paraffin-embedded human breast cancer tissues reveals a link to tumor progression.
Ma Y; Ambannavar R; Stephans J; Jeong J; Dei Rossi A; Liu ML; Friedman AJ; Londry JJ; Abramson R; Beasley EM; Baker J; Levy S; Qu K
PLoS One; 2014; 9(4):e94202. PubMed ID: 24727804
[TBL] [Abstract][Full Text] [Related]
23. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
Rauh-Adelmann C; Lau KM; Sabeti N; Long JP; Mok SC; Ho SM
Mol Carcinog; 2000 Aug; 28(4):236-46. PubMed ID: 10972993
[TBL] [Abstract][Full Text] [Related]
24. Transcriptome Sequencing: RNA-Seq.
Zhang H; He L; Cai L
Methods Mol Biol; 2018; 1754():15-27. PubMed ID: 29536435
[TBL] [Abstract][Full Text] [Related]
25. INTEGRATE: gene fusion discovery using whole genome and transcriptome data.
Zhang J; White NM; Schmidt HK; Fulton RS; Tomlinson C; Warren WC; Wilson RK; Maher CA
Genome Res; 2016 Jan; 26(1):108-18. PubMed ID: 26556708
[TBL] [Abstract][Full Text] [Related]
26. Reanalysis of RNA-sequencing data reveals several additional fusion genes with multiple isoforms.
Kangaspeska S; Hultsch S; Edgren H; Nicorici D; Murumägi A; Kallioniemi O
PLoS One; 2012; 7(10):e48745. PubMed ID: 23119097
[TBL] [Abstract][Full Text] [Related]
27. Open-access synthetic spike-in mRNA-seq data for cancer gene fusions.
Tembe WD; Pond SJ; Legendre C; Chuang HY; Liang WS; Kim NE; Montel V; Wong S; McDaniel TK; Craig DW; Carpten JD
BMC Genomics; 2014 Sep; 15(1):824. PubMed ID: 25266161
[TBL] [Abstract][Full Text] [Related]
28. An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers.
Przybytkowski E; Davis T; Hosny A; Eismann J; Matulonis UA; Wulf GM; Nabavi S
BMC Cancer; 2020 Mar; 20(1):197. PubMed ID: 32164626
[TBL] [Abstract][Full Text] [Related]
29. Case Study: Systematic Detection and Prioritization of Gene Fusions in Cancer by RNA-Seq: A DIY Toolkit.
Vats P; Chinnaiyan AM; Kumar-Sinha C
Methods Mol Biol; 2020; 2079():69-79. PubMed ID: 31728962
[TBL] [Abstract][Full Text] [Related]
30. An Efficient Method for Identifying Gene Fusions by Targeted RNA Sequencing from Fresh Frozen and FFPE Samples.
Scolnick JA; Dimon M; Wang IC; Huelga SC; Amorese DA
PLoS One; 2015; 10(7):e0128916. PubMed ID: 26132974
[TBL] [Abstract][Full Text] [Related]
31. BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations.
Holstege H; Horlings HM; Velds A; Langerød A; Børresen-Dale AL; van de Vijver MJ; Nederlof PM; Jonkers J
BMC Cancer; 2010 Nov; 10():654. PubMed ID: 21118481
[TBL] [Abstract][Full Text] [Related]
32. Next-Generation Sequencing-Based Detection of Germline Copy Number Variations in BRCA1/BRCA2: Validation of a One-Step Diagnostic Workflow.
Schmidt AY; Hansen TVO; Ahlborn LB; Jønson L; Yde CW; Nielsen FC
J Mol Diagn; 2017 Nov; 19(6):809-816. PubMed ID: 28822785
[TBL] [Abstract][Full Text] [Related]
33. Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer.
Annunziato S; de Ruiter JR; Henneman L; Brambillasca CS; Lutz C; Vaillant F; Ferrante F; Drenth AP; van der Burg E; Siteur B; van Gerwen B; de Bruijn R; van Miltenburg MH; Huijbers IJ; van de Ven M; Visvader JE; Lindeman GJ; Wessels LFA; Jonkers J
Nat Commun; 2019 Jan; 10(1):397. PubMed ID: 30674894
[TBL] [Abstract][Full Text] [Related]
34. Somatic BRCA1 mutations in clinically sporadic breast cancer with medullary histological features.
Rechsteiner M; Dedes K; Fink D; Pestalozzi B; Sobottka B; Moch H; Wild P; Varga Z
J Cancer Res Clin Oncol; 2018 May; 144(5):865-874. PubMed ID: 29453630
[TBL] [Abstract][Full Text] [Related]
35. Somatic structural rearrangements in genetically engineered mouse mammary tumors.
Varela I; Klijn C; Stephens PJ; Mudie LJ; Stebbings L; Galappaththige D; van der Gulden H; Schut E; Klarenbeek S; Campbell PJ; Wessels LF; Stratton MR; Jonkers J; Futreal PA; Adams DJ
Genome Biol; 2010; 11(10):R100. PubMed ID: 20942901
[TBL] [Abstract][Full Text] [Related]
36. Discovering chimeric transcripts in paired-end RNA-seq data by using EricScript.
Benelli M; Pescucci C; Marseglia G; Severgnini M; Torricelli F; Magi A
Bioinformatics; 2012 Dec; 28(24):3232-9. PubMed ID: 23093608
[TBL] [Abstract][Full Text] [Related]
37.
Lips EH; Debipersad RD; Scheerman CE; Mulder L; Sonke GS; van der Kolk LE; Wesseling J; Hogervorst FB; Nederlof PM
Clin Cancer Res; 2017 Mar; 23(5):1236-1241. PubMed ID: 27620280
[No Abstract] [Full Text] [Related]
38. Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number data.
Shah N; Lankerovich M; Lee H; Yoon JG; Schroeder B; Foltz G
BMC Genomics; 2013 Nov; 14(1):818. PubMed ID: 24261984
[TBL] [Abstract][Full Text] [Related]
39. Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.
Joosse SA; Brandwijk KI; Devilee P; Wesseling J; Hogervorst FB; Verhoef S; Nederlof PM
Breast Cancer Res Treat; 2012 Apr; 132(2):379-89. PubMed ID: 20614180
[TBL] [Abstract][Full Text] [Related]
40. RNA profiling reveals familial aggregation of molecular subtypes in non-BRCA1/2 breast cancer families.
Larsen MJ; Thomassen M; Tan Q; Lænkholm AV; Bak M; Sørensen KP; Andersen MK; Kruse TA; Gerdes AM
BMC Med Genomics; 2014 Jan; 7():9. PubMed ID: 24479546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
